| Dear Subscriber, |
| Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
| ADHD News | |
| Brain Imaging Study Of Preschoolers With ADHD Detects Brain Differences Linked To Symptoms In a study published today in the Clinical Neuropsychologist (e-publication ahead of print), researchers from the Kennedy Krieger Institute found differences in the brain development of preschool children with symptoms of Attention-deficit/Hyperactivity Disorder (ADHD). | 10 June 2011 |
| Aid / Disasters News | |
| HHS Toolkit Of Public Health Emergency Text Messages Now Available A new toolkit of prepared cell phone text messages advising people how to protect their health after a disaster is available now through the U.S. Department of Health and Human Services. These messages support state and local emergency managers in disaster response and are available online here. | 10 June 2011 |
| Alcohol / Addiction / Illegal Drugs News | |
| Funding Will Support Development Of Therapeutics For Treating Substance Abuse The Scripps Research Institute has been awarded a $2.2 million grant from the National Institutes of Health (NIH) to develop novel therapeutics for the treatment of addiction to multiple substances in a national effort with the University of Kansas. | 10 June 2011 |
| Allergy News | |
| FDA Accepts Filing Of New Drug Application For Nycomed's Ciclesonide HFA Nasal Aerosol Nycomed's licensing partner Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation. | 10 June 2011 |
| Alzheimer's / Dementia News | |
| Dementia Community Roadshow Provides Lifeline To 100,000 Families, UK On 14 June Alzheimer's Society, Alzheimer Scotland and Tesco will launch the UK's first ever Dementia Community Roadshow.With more than a million people predicted to be living with undiagnosed dementia in 2021, the Roadshow is an essential first step in providing much needed information and advice about the condition. | 10 June 2011 |
| Anxiety / Stress News | |
| Ingratiation Used By Politically Savvy Individuals Neutralizes Psychological Distress Savvy career minded individuals have known for some time that ingratiating oneself to the boss and others - perhaps more commonly known as 'sucking up'- can help move them up the corporate ladder more quickly. | 10 June 2011 |
| Arthritis / Rheumatology News | |
| Arthritis Epidemic Looming In UK, High Heels Partly To Blame Inadquate footwear such as high heels is partly to blame for the arthritis problem that is in danger of reaching epidemic proportions in the UK where already one in four adults has a muskuloskeletal condition, with 60% of arthritis cases being in the feet. | 10 June 2011 |
| Hospital For Special Surgery To Host International Osteoarthritis Summit Osteoarthritis (OA) is one of the most pressing health care challenges of our time, affecting 27 million Americans. In an effort to elucidate the latest information in diagnosis, treatment, research and prevention, Hospital for Special Surgery (HSS) will host an international Osteoarthritis Summit on June 17 and June 18. | 10 June 2011 |
| SANUWAVE Extracorporeal Shock Wave Technology Shown To Prevent And Repair Osteoarthritis Damage In Preclinical Model SANUWAVE Health, Inc. (OTC/BB: SNWV), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported the results of published preclinical osteoarthritis research conducted in Taiwan utilizing extracorporeal shock wave technology (ESWT) to prevent and repair osteoarthritis damage. | 10 June 2011 |
| Asbestos / Mesothelioma News | |
| Deaths And Major Morbidity From Asbestos-Related Diseases In Asia Likely To Surge In Next 20 Years: 'The Asian Asbestos Tsunami' Warning An alarming new article in Respirology issues a serious warning of massive rises in deaths from asbestos-related lung diseases in Asia. Dr Ken Takahashi, Acting Director of the WHO Collaborating Center for Occupational Health, and his team put together important data on asbestos use in 47 Asian countries in this landmark article. | 10 June 2011 |
| Biology / Biochemistry News | |
| Improved Modeling Of Biological Systems Using New Parallelization Technique Researchers at North Carolina State University have developed a new technique for using multi-core chips more efficiently, significantly enhancing a computer's ability to build computer models of biological systems. | 10 June 2011 |
| Regulatory Mechanism For Gene Expression In The Visual System Uncovered By Biologists Biologists have uncovered a key regulatory mechanism used for gene expression in the visual system. Their findings, which appear in the latest issue of the journal Cell, offer new insights into the complexity behind the genetic make-up of biological systems. | 10 June 2011 |
| Key Function Of Enzyme Involved In RNA Processing Described By New Research Researchers at the Case Western Reserve University School of Medicine have identified a cellular mechanism that is critical in maintaining normal cell function.In their work, the researchers led by Eckhard Jankowsky, PhD, researcher and associate professor in the Center for RNA Molecular Biology at the Case Western Reserve University School of Medicine, examined the function of TRAMP, a protein complex involved in the processing of RNA or ribonucleic acid within the cell. | 10 June 2011 |
| Chemists Devise Better Way To Prepare Workhorse Molecules In chemistry, so-called aromatic molecules compose a large and versatile family of chemical compounds that are the stuff of pharmaceuticals, electronic materials and consumer products ranging from sunscreen to plastic soda bottles. | 10 June 2011 |
| UGA Researcher Leads Discovery Of A New Driving Force For Chemical Reactions New research just published in the journal Science by a team of chemists at the University of Georgia and colleagues in Germany shows for the first time that a mechanism called tunneling control may drive chemical reactions in directions unexpected from traditional theories. | 10 June 2011 |
| New Genetic Technique Converts Skin Cells Into Brain Cells A research breakthrough has proven that it is possible to reprogram mature cells from human skin directly into brain cells, without passing through the stem cell stage. The unexpectedly simple technique involves activating three genes in the skin cells; genes which are already known to be active in the formation of brain cells at the foetal stage. | 10 June 2011 |
| Blood / Hematology News | |
| Blinatumomab Achieved 75% Complete Remission In Acute Relapsing Lymphoblastic Leukemia Patients 75% of acute lymphoblastic leukemia patients who had relapsed after standard therapy achieved complete remission with blinatumomab, a medication designed to harness T cells that destroy cancer cells. | 10 June 2011 |
| U-M Researchers Find Potential New Way To Fight Sepsis By digging a little deeper, researchers may have found a potential target for reversing the deadly blood infection sepsis. Scientists at the University of Michigan Health System looked at microRNA, a type of RNA that does not code for a protein itself but that can regulate the expression of other genes and proteins. | 10 June 2011 |
| Study Demonstrates Micromet's Blinatumomab Produces High Single-Agent Activity In Patients With Relapsed Acute Lymphoblastic Leukemia Data to be presented tomorrow at the 16th Annual Meeting of the European Hematology Association (EHA) in London, UK, show that Micromet's blinatumomab produced a high complete remission rate in adult patients with acute lymphoblastic leukemia (ALL) who had relapsed following treatment with standard therapy. | 10 June 2011 |
| Molecular Biologists Discover The Cause Of A Rare Type Of Leukemia During the annual meeting of the European Hematology Association (EHA) professor E. Tiacci from the Institute of Hematology in Perugia, Italy will present groundbreaking news on the cause of a specific, rare subtype of leukemia, so-called hairy cell leukemia. | 10 June 2011 |
| New Therapeutic Agent In Development Shows Statistically Significant Positive Outcomes In Patients With Debilitating, Life-threatening Blood Cancer The largest clinical program to date in patients with a potentially life-threatening blood cancer known as myelofibrosis (MF) has shown that a new therapeutic candidate, ruxolitinib, provided clinical benefits to patients compared to placebo and best available therapy. | 10 June 2011 |
| Cord Blood Banks Contain More Than 500.000 Umbilical Cord Blood Units Advantages Of Cord Blood Stem Cell Transplantation Established Since the first human cord blood transplant, performed in 1988, the safety and efficacy of umbilical cord blood transplantation in both children and adults with a variety of malignant and non-malignant diseases have been clearly established. | 10 June 2011 |
| Remission Duration Of Lymphoma Doubled By New Therapy Clinical research has shown that recurrence of Mantle Cell Lymphoma, a variant of malignant lymphoma, can be reduced by almost 50% in patients who receive maintenance treatment with the antibody rituximab. | 10 June 2011 |
| Acute Myeloid Leukemia: Novel Developments In Treatment And Diagnosis Patients With Acute Myeloid Leukemia Receive Unnecessary High Doses Chemotherapy Patients with the most common form of leukemia (acute myeloid leukemia) receive ten times more chemotherapy than necessary. This was revealed by a team of Dutch hematologists. 'It is expected that this finding will lead to worldwide adjustments in the doses so that patients will experience less side-effects' says Dr Bob Löwenberg, Professor of Hematology at the Erasmus University Medical Center in Rotterdam, The Netherlands. | 10 June 2011 |
| Bones / Orthopedics News | |
| Arthritis Epidemic Looming In UK, High Heels Partly To Blame Inadquate footwear such as high heels is partly to blame for the arthritis problem that is in danger of reaching epidemic proportions in the UK where already one in four adults has a muskuloskeletal condition, with 60% of arthritis cases being in the feet. | 10 June 2011 |
| Hospital For Special Surgery To Host International Osteoarthritis Summit Osteoarthritis (OA) is one of the most pressing health care challenges of our time, affecting 27 million Americans. In an effort to elucidate the latest information in diagnosis, treatment, research and prevention, Hospital for Special Surgery (HSS) will host an international Osteoarthritis Summit on June 17 and June 18. | 10 June 2011 |
| SANUWAVE Extracorporeal Shock Wave Technology Shown To Prevent And Repair Osteoarthritis Damage In Preclinical Model SANUWAVE Health, Inc. (OTC/BB: SNWV), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported the results of published preclinical osteoarthritis research conducted in Taiwan utilizing extracorporeal shock wave technology (ESWT) to prevent and repair osteoarthritis damage. | 10 June 2011 |
| Breast Cancer News | |
| Study Confirms Safety, Cancer-Targeting Ability Of Nutrient In Broccoli, Other Vegetables Sulforaphane, one of the primary phytochemicals in broccoli and other cruciferous vegetables that helps them prevent cancer, has been shown for the first time to selectively target and kill cancer cells while leaving normal prostate cells healthy and unaffected. | 10 June 2011 |
| Signaling Pathways Point To Vulnerability In Breast Cancer Stem Cells Whitehead Institute researchers have identified signals from breast epithelial cells that can induce those cells to transition to and maintain a mesenchymal and stem cell-like cell state that imbues both normal and cancer cells with a greater ability to migrate and self-renew. | 10 June 2011 |
| Cancer / Oncology News | |
| Blinatumomab Achieved 75% Complete Remission In Acute Relapsing Lymphoblastic Leukemia Patients 75% of acute lymphoblastic leukemia patients who had relapsed after standard therapy achieved complete remission with blinatumomab, a medication designed to harness T cells that destroy cancer cells. | 10 June 2011 |
| Study Demonstrates Micromet's Blinatumomab Produces High Single-Agent Activity In Patients With Relapsed Acute Lymphoblastic Leukemia Data to be presented tomorrow at the 16th Annual Meeting of the European Hematology Association (EHA) in London, UK, show that Micromet's blinatumomab produced a high complete remission rate in adult patients with acute lymphoblastic leukemia (ALL) who had relapsed following treatment with standard therapy. | 10 June 2011 |
| Stem Cell Transplantation: A New Strategy For Treating Multiple Myeloma A new study has indicated the possible advantages of stem cell transplantation for patients with Multiple Myeloma, a cancer of plasma cells. Dr Antonio Palumbo: "This study shows a longer progression-free survival time with hematopoietic stem cell transplantation in comparison to conventional chemotherapy. | 10 June 2011 |
| Molecular Biologists Discover The Cause Of A Rare Type Of Leukemia During the annual meeting of the European Hematology Association (EHA) professor E. Tiacci from the Institute of Hematology in Perugia, Italy will present groundbreaking news on the cause of a specific, rare subtype of leukemia, so-called hairy cell leukemia. | 10 June 2011 |
| New Therapeutic Agent In Development Shows Statistically Significant Positive Outcomes In Patients With Debilitating, Life-threatening Blood Cancer The largest clinical program to date in patients with a potentially life-threatening blood cancer known as myelofibrosis (MF) has shown that a new therapeutic candidate, ruxolitinib, provided clinical benefits to patients compared to placebo and best available therapy. | 10 June 2011 |
| Stem Cell Time Bombs Cause Leukaemia Relapse, UK Leukaemia "stem cells" can lie dormant in the body for a decade or more after a child achieves remission before being reactivated and causing a relapse, a new study shows. Senior author Professor Mel Greaves from The Institute of Cancer Research (ICR) cautioned that the findings should not unduly concern parents whose children have previously suffered acute lymphoblastic leukaemia (ALL) as the leukaemia returning after very many years of remission is rare. | 10 June 2011 |
| How Killer Immune Cells Avoid Killing Themselves After eight years of work, researchers have unearthed what has been a well-kept secret of our immune system's success. The findings published online on June 9th in Immunity, a Cell Press publication, offer an explanation for how specialized immune cells are able to kill infected or cancerous cells without killing themselves in the process. | 10 June 2011 |
| ImmunoCellular Therapeutics Ltd. Expands Phase II Trial Of ICT-107 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular" or the "Company") (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. | 10 June 2011 |
| Phase 3 Lymphoseek (Tilmanocept) Study Results Featured At Society Of Nuclear Medicine Annual Meeting Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that full results from the NEO3-05 study, demonstrating Lymphoseek® (99mTc-tilmanocept) met all primary and secondary endpoints in intraoperative lymphatic mapping (ILM) procedures. | 10 June 2011 |
| MDxHealth And Merck KGaA Extend Agreement For Use Of MGMT Assay In Brain Cancer Clinical Trials MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized medicine, announced today that it will extend its agreement with Merck KGaA, Darmstadt, Germany, for use of MDxHealth's MGMT assay in Merck KGaA's brain cancer clinical trials. | 10 June 2011 |
| Remission Duration Of Lymphoma Doubled By New Therapy Clinical research has shown that recurrence of Mantle Cell Lymphoma, a variant of malignant lymphoma, can be reduced by almost 50% in patients who receive maintenance treatment with the antibody rituximab. | 10 June 2011 |
| UCLA Researchers Given Early Access To Leading-Edge Technologies An agreement between UCLA and Roche will provide stem cell and cancer researchers with leading-edge technologies that will drive research capabilities and further the understanding of complex disease. | 10 June 2011 |
| Cancer Experts Offer Four Tips For Healthy Grilling It's that time of year again. Hot weather sets picnic fever - and the nation's barbeque grills - ablaze; in fact, according to the Hearth, Patio and Barbeque Association, 4 out of 5 American households will fire up backyard grills this summer. | 10 June 2011 |
| Cardiovascular / Cardiology News | |
| Cardiac Biomarker ST2 Predicts Outcomes In Ambulatory Heart Failure Patients The novel cardiac biomarker ST2 was highlighted in a presentation at last month's 2011 Heart Failure Congress of the European Society of Cardiology in Gothenburg, Sweden. As this study and others have demonstrated, a patient's ST2 level can help a physician better predict prognosis in ambulatory, chronic heart failure patients, which can allow physicians to more appropriately tailor care. | 10 June 2011 |
| St. Joseph's Children's Hospital First In Tampa Bay To Implant Pulmonary Valve Without Open-Heart Surgery When cardiologists at St. Joseph's Children's Hospital told 21-year-old Adam Romano that he needed to have his pulmonary valve replaced, the diagnosis was not a surprise. Born with the congenital heart defect Tetralogy of Fallot, Adam underwent open-heart surgery when he was 2 years old and his family has anticipated the need for another open-heart surgery for the past decade. | 10 June 2011 |
| Caregivers / Homecare News | |
| Report Reveals Care Industry On Brink Of Collapse, UK A new UNISON report, delving into the running and funding of the care industry, reveals that the collapse of Southern Cross may not be a one-off, as a number of other social care companies are also on the brink. | 10 June 2011 |
| Clinical Trials / Drug Trials News | |
| ImmunoCellular Therapeutics Ltd. Expands Phase II Trial Of ICT-107 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular" or the "Company") (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. | 10 June 2011 |
| MDxHealth And Merck KGaA Extend Agreement For Use Of MGMT Assay In Brain Cancer Clinical Trials MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized medicine, announced today that it will extend its agreement with Merck KGaA, Darmstadt, Germany, for use of MDxHealth's MGMT assay in Merck KGaA's brain cancer clinical trials. | 10 June 2011 |
| PatientsLikeMe Launches New Feature For Patients To Accelerate Clinical Trial Enrollment Today, PatientsLikeMe announces the launch of a new feature that helps patients find clinical trials that are right for them and helps companies find patients who are right for their trial. The feature, which updates daily with all of the trial information listed on ClinicalTrial. | 10 June 2011 |
| Perceptive Informatics® Takes Lead In Practical Application Of Response Criteria For Lymphoma And Leukemia In Clinical Trials Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), announced that it is taking a lead role in the biopharmaceutical industry to advance the practical application of revised response criteria for Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) to clinical trials. | 10 June 2011 |
| Abbott Reports Interim Results From Phase III Open-Label Study Of Investigational Treatment For Advanced Parkinson's Disease Interim efficacy and safety results from a long-term, 54-week, Phase III open-label study of Abbott's investigational treatment for advanced Parkinson's disease showed that patients treated with levodopa-carbidopa intestinal gel (LCIG) for 12 weeks reported a decrease in "off" time and an increase in "on" time without troublesome dyskinesias. | 10 June 2011 |
| Conferences News | |
| GPs Say They Don't Have The Skills To Run NHS Budgets - New Survey From Biggest GP Conference This Year, UK A new survey has delivered a damning indictment of the Prime Minister's revised NHS plans. GPs and primary healthcare professionals attending the Health Commissioning conference at Olympia on Wednesday, 15th and Thursday, 16th June have raised serious and urgent concerns with the government's approach to healthcare reforms, and with the Prime Minister's personal commitments. | 10 June 2011 |
| COPD News | |
| Forest Laboratories, Inc. Announces Availability Of Daliresp™ In Pharmacies Forest Laboratories, Inc. (NYSE: FRX) announced today that Daliresp™ (roflumilast) will be available in pharmacies throughout the United States by mid-June. The U.S. Food and Drug Administration (FDA) recently approved Daliresp as a treatment to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. | 10 June 2011 |
| Cosmetic Medicine / Plastic Surgery News | |
| UK Cosmetic Surgeon Slams Plastic Surgery 'Party' A leading Midlands' cosmetic surgeon has slammed a decision by Birmingham based Transpire Cosmetic Surgery to sponsor a plastic surgery party, saying it trivialises serious life-changing cosmetic procedures. | 10 June 2011 |
| Ethicon Endo-Surgery Introduces ENDOPATH® XCEL™ With OPTIVIEW® Technology, Only 5mm Trocar Designed To Mitigate Smudging Of Endoscope Ethicon Endo-Surgery (EES) announced the launch of a new 5mm ENDOPATH® XCEL™ trocar enhanced with OPTIVIEW® Technology, the only trocar designed to mitigate smudging of the endoscope or laparoscope during surgical procedures. | 10 June 2011 |
| Crohn's / IBD News | |
| Congress: Alex German To Take The Frustration Out Of Canine IBD, UK When a dog turns up in their consulting room with chronic diarrhoea, vomiting and weight loss, then it is quite likely that the vet will call it a case of inflammatory bowel disease. But that is probably the only thing that they can say with any confidence after identifying one of the most enigmatic and frustrating conditions seen in small animal practice. | 10 June 2011 |
| Cystic Fibrosis News | |
| Phase 3 STRIVE Study Of VX-770 Showed Durable Improvements In Lung Function And Other Measures Of Disease Among People With A Specific Type Of CF Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the final results from its pivotal Phase 3 STRIVE study that evaluated VX-770, a medicine in development that targets the defective protein that causes cystic fibrosis (CF). | 10 June 2011 |
| Mutations In Essential Genes Often Cause Rare Diseases Mutations in genes essential to survival are behind so-called orphan diseases, explaining in part why these diseases are rare and often deadly, according to a study appearing in The American Journal of Human Genetics. | 10 June 2011 |
| Phase 2 Study Of Two Potential CF Therapies - VX-770 And VX-809 - Shows Promising Results In Patients With Most Common Mutation Vertex Pharmaceuticals Incorporated and the Cystic Fibrosis Foundation today announced promising results from an ongoing Phase 2 study evaluating combinations of VX-770 and VX-809, potential medicines designed to treat the defective protein that causes cystic fibrosis. | 10 June 2011 |
| Dermatology News | |
| Woman Receives Full Face Transplant After Being Mauled By A Chimpanzee Charla Nash, 57, whose face was mauled by a furious 200-pound pet chimpanzee in February 2009, has undergone a full face transplant at Brigham and Women's Hospital, Dr. Bohdan Pomahac, medical team leader announced. | 10 June 2011 |
| Moberg Derma AB: Moberg Derma Obtains Approval For Treatment For Atopic Eczema And Dry Skin Moberg Derma AB (publ.) (STO:MOB) today announced that CE mark has been granted for Kaprolac Skin Repair & Hydration, a product designed to treat atopic eczema and dry skin. This CE mark provides authorization to market and sell the product in the EU/EEA. | 10 June 2011 |
| Diabetes News | |
| Diabetes Drugs Actos And Competact Suspended In France And Germany, Potential Bladder Cancer Risk After a study showed a slight increased risk of developing bladder cancer among patients taking Actos (pioglitazone) and Competact (metformin with pioglitazone), French regulators announced that they have suspended the use of Actos and Competact, both diabetes medications. | 10 June 2011 |
| The Juvenile Diabetes Research Foundation And Selecta Biosciences Enter Research Collaboration For Vaccines For Type 1 Diabetes The Juvenile Diabetes Research Foundation (JDRF) and Selecta Biosciences, Inc. announced today that they have established a research collaboration to support Selecta's development of a vaccine technology, which may subsequently help to better treat and potentially prevent type 1 diabetes. | 10 June 2011 |
| Promising New Imaging Tech For Diagnosis Of Cardiovascular Disease, Diabetes Researchers have developed a new type of imaging technology to diagnose cardiovascular disease and other disorders by measuring ultrasound signals from molecules exposed to a fast-pulsing laser. | 10 June 2011 |
| Research Team Tests Alternative Approach To Treating Diabetes In a mouse study, scientists at Mayo Clinic Florida have demonstrated the feasibility of a promising new strategy for treating human type 2 diabetes, which affects more than 200 million people worldwide. | 10 June 2011 |
| Eczema / Psoriasis News | |
| Moberg Derma AB: Moberg Derma Obtains Approval For Treatment For Atopic Eczema And Dry Skin Moberg Derma AB (publ.) (STO:MOB) today announced that CE mark has been granted for Kaprolac Skin Repair & Hydration, a product designed to treat atopic eczema and dry skin. This CE mark provides authorization to market and sell the product in the EU/EEA. | 10 June 2011 |
| Eye Health / Blindness News | |
| Researchers Uncover The Source Of The Visual System's 'False Alarms' On rare occasion, the light-sensing photoreceptor cells in the eye misfire and signal to the brain as if they have captured photons, when in reality they haven't. For years this phenomenon remained a mystery. | 10 June 2011 |
| Aiming To Eradicate Blinding Diseases, Mass. Eye And Ear And Schepens Eye Research Institute Join Forces The Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute have announced that they are combining forces to create the world's largest and most robust basic and clinical ophthalmology research enterprise with full spectrum bench-to-bedside research that will translate more quickly into better treatment for blinding diseases and ultimately cures. | 10 June 2011 |
| Scientists Find How Rogue Cells 'Eat Our Eyes' Vision scientists have identified a key player in macular degeneration (MD), raising hope for a treatment for the currently incurable blinding disease.The studies reveal how light-damaged eyes invoke an out-of-control immune response, resulting in white blood cells invading the retina and leaving behind proteins that kill the light sensitive vision cells. | 10 June 2011 |
| Regulatory Mechanism For Gene Expression In The Visual System Uncovered By Biologists Biologists have uncovered a key regulatory mechanism used for gene expression in the visual system. Their findings, which appear in the latest issue of the journal Cell, offer new insights into the complexity behind the genetic make-up of biological systems. | 10 June 2011 |
| Genetics News | |
| U-M Researchers Find Potential New Way To Fight Sepsis By digging a little deeper, researchers may have found a potential target for reversing the deadly blood infection sepsis. Scientists at the University of Michigan Health System looked at microRNA, a type of RNA that does not code for a protein itself but that can regulate the expression of other genes and proteins. | 10 June 2011 |
| Fragile X Protein Acts As Toggle Switch In Brain Cells New research shows how the protein missing in fragile X syndrome - the most common inherited form of intellectual disability - acts as a molecular toggle switch in brain cells.The fragile X protein, called FMRP, hooks up with a group of molecules called microRNAs to switch the production of other proteins on and off in response to chemical signals, scientists at Emory University School of Medicine have discovered. | 10 June 2011 |
| Grant To Pursue Innovative Research To Develop Personalized Medicine The Research Institute of the McGill University Health Centre (RI-MUHC) was one of three winners in the Fonds de la recherche en sante du Quebec (FRSQ) competition 2011-2012. The RI-MUHC won in the category of Projects for innovative strategic development aimed at supporting projects essential to maintaining the competitiveness of a research centre. | 10 June 2011 |
| UCLA Researchers Given Early Access To Leading-Edge Technologies An agreement between UCLA and Roche will provide stem cell and cancer researchers with leading-edge technologies that will drive research capabilities and further the understanding of complex disease. | 10 June 2011 |
| New Evidence Of Genetic 'Arms Race' Against Malaria For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back. | 10 June 2011 |
| Regulatory Mechanism For Gene Expression In The Visual System Uncovered By Biologists Biologists have uncovered a key regulatory mechanism used for gene expression in the visual system. Their findings, which appear in the latest issue of the journal Cell, offer new insights into the complexity behind the genetic make-up of biological systems. | 10 June 2011 |
| Key Function Of Enzyme Involved In RNA Processing Described By New Research Researchers at the Case Western Reserve University School of Medicine have identified a cellular mechanism that is critical in maintaining normal cell function.In their work, the researchers led by Eckhard Jankowsky, PhD, researcher and associate professor in the Center for RNA Molecular Biology at the Case Western Reserve University School of Medicine, examined the function of TRAMP, a protein complex involved in the processing of RNA or ribonucleic acid within the cell. | 10 June 2011 |
| Mutations In Essential Genes Often Cause Rare Diseases Mutations in genes essential to survival are behind so-called orphan diseases, explaining in part why these diseases are rare and often deadly, according to a study appearing in The American Journal of Human Genetics. | 10 June 2011 |
| Orphan Diseases Often Caused By Essential-To-Survival Gene Mutations So-called orphan diseases are rare and frequently deadly because often there are mutations in essential-to-survival genes, researchers from Cincinnati Children's Hospital Medical Center explain in The American Journal of Human Genetics. | 10 June 2011 |
| Heart Disease News | |
| Cardiac Biomarker ST2 Predicts Outcomes In Ambulatory Heart Failure Patients The novel cardiac biomarker ST2 was highlighted in a presentation at last month's 2011 Heart Failure Congress of the European Society of Cardiology in Gothenburg, Sweden. As this study and others have demonstrated, a patient's ST2 level can help a physician better predict prognosis in ambulatory, chronic heart failure patients, which can allow physicians to more appropriately tailor care. | 10 June 2011 |
| Promising New Imaging Tech For Diagnosis Of Cardiovascular Disease, Diabetes Researchers have developed a new type of imaging technology to diagnose cardiovascular disease and other disorders by measuring ultrasound signals from molecules exposed to a fast-pulsing laser. | 10 June 2011 |
| HIV / AIDS News | |
| World Leaders Launch Plan To Eliminate New HIV Infections Among Children By 2015 World leaders gathered in New York for the 2011 United Nations High Level Meeting on AIDS have today launched a Global Plan that will make significant strides towards eliminating new HIV infections among children by 2015 and keeping their mothers alive. | 10 June 2011 |
| Target Of 15 Million People On HIV Treatment By 2015 Secured At AIDS Summit On the heels of new evidence that shows HIV treatment is also HIV prevention, governments meeting at a UN Summit on AIDS have taken a critical step by committing to reach 15 million people with HIV treatment by 2015 - but they must take immediate concrete action to make this treatment target a reality, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today. | 10 June 2011 |
| At AIDS Summit, UN Must Focus On Key Populations And Human Rights To Meet Goal Of Zero New Infections As country delegations to the United Nations gather this week to strengthen their commitment to ending the global HIV epidemic by issuing a new political declaration on AIDS, the Global Forum on MSM & HIV (MSMGF) calls for a re-thinking of global AIDS strategy that elevates evidence-based policies, key populations, and human rights as core pillars of the response. | 10 June 2011 |
| Immune System / Vaccines News | |
| Developing Countries Make Record Demand For Life-Saving Vaccines A record 50 GAVI eligible countries have applied for vaccine funding from the GAVI Alliance during the organisation's latest application round, reported GAVI officials today. The number of countries is nearly double the previous record in 2007 when 27 countries requested support to introduce new or underused vaccines. | 10 June 2011 |
| How Killer Immune Cells Avoid Killing Themselves After eight years of work, researchers have unearthed what has been a well-kept secret of our immune system's success. The findings published online on June 9th in Immunity, a Cell Press publication, offer an explanation for how specialized immune cells are able to kill infected or cancerous cells without killing themselves in the process. | 10 June 2011 |
| The Juvenile Diabetes Research Foundation And Selecta Biosciences Enter Research Collaboration For Vaccines For Type 1 Diabetes The Juvenile Diabetes Research Foundation (JDRF) and Selecta Biosciences, Inc. announced today that they have established a research collaboration to support Selecta's development of a vaccine technology, which may subsequently help to better treat and potentially prevent type 1 diabetes. | 10 June 2011 |
| For 'Membrane Mimic' Technology Structural Biologist Wins $150K Walter and Eliza Hall Institute researcher Dr Matthew Call has been awarded a $150,000 Victorian Endowment for Science, Knowledge and Innovation (VESKI) Fellowship by the Victorian Government to continue his novel studies of immune cell receptors and signalling. | 10 June 2011 |
| Athletes' Health Boosted By Non-Alcoholic Wheat Beer Many amateur athletes have long suspected what research scientists for the Department of Preventative and Rehabilitative Sports Medicine of the Technische Universitaet Muenchen at Klinikum rechts der Isar have now made official: Documented proof, gathered during the world's largest study of marathons, "Be-MaGIC" (beer, marathons, genetics, inflammation and the cardiovascular system), that the consumption of non-alcoholic weissbier, or wheat beer, has a positive effect on athletes' health. | 10 June 2011 |
| Dramatic Fall In Cases Of Meningitis A In Three West African Nations After New Vaccine Introduction Burkina Faso, Mali, and Niger report the lowest number of confirmed meningitis A cases ever recorded during an epidemic season this year following the successful introduction of a new vaccine that could eliminate the primary cause of the deadly disease from Africa's meningitis belt, announced the Meningitis Vaccine Project (MVP) today, which spearheaded development of the vaccine. | 10 June 2011 |
| Cellectis And VitamFero Collaborate To Develop Vaccines Against Parasitic Infection Cellectis (Alternext: ALCLS), the genome engineering specialist, and VitamFero, a biotech company of the Genopole® portfolio developing new vaccines against parasite infections, today announced the signing of a research, development and licensing partnership agreement. | 10 June 2011 |
| Infectious Diseases / Bacteria / Viruses News | |
| E. Coli Outbreak, Vegetable Sprouts Most Likely The Cause, Say German Authorities The current E. coli outbreak probably originated in vegetable sprouts from an organic farm in northern Germany, spokespeople from the Robert Koch Institute, the Institute of Risk Management and the Ministry of Consumer Protection in Germany announced today. | 10 June 2011 |
| Developing Countries Make Record Demand For Life-Saving Vaccines A record 50 GAVI eligible countries have applied for vaccine funding from the GAVI Alliance during the organisation's latest application round, reported GAVI officials today. The number of countries is nearly double the previous record in 2007 when 27 countries requested support to introduce new or underused vaccines. | 10 June 2011 |
| How Killer Immune Cells Avoid Killing Themselves After eight years of work, researchers have unearthed what has been a well-kept secret of our immune system's success. The findings published online on June 9th in Immunity, a Cell Press publication, offer an explanation for how specialized immune cells are able to kill infected or cancerous cells without killing themselves in the process. | 10 June 2011 |
| Pall GeneDisc(R) Technology A Key Detection Tool In E.coli Outbreak Pall Corporation's (NYSE: PLL) GeneDisc® System is helping German authorities screen for a deadly strain of E.coli that has sickened nearly 3000 people and disrupted that nation's food industry. | 10 June 2011 |
| Dramatic Fall In Cases Of Meningitis A In Three West African Nations After New Vaccine Introduction Burkina Faso, Mali, and Niger report the lowest number of confirmed meningitis A cases ever recorded during an epidemic season this year following the successful introduction of a new vaccine that could eliminate the primary cause of the deadly disease from Africa's meningitis belt, announced the Meningitis Vaccine Project (MVP) today, which spearheaded development of the vaccine. | 10 June 2011 |
| At AIDS Summit, UN Must Focus On Key Populations And Human Rights To Meet Goal Of Zero New Infections As country delegations to the United Nations gather this week to strengthen their commitment to ending the global HIV epidemic by issuing a new political declaration on AIDS, the Global Forum on MSM & HIV (MSMGF) calls for a re-thinking of global AIDS strategy that elevates evidence-based policies, key populations, and human rights as core pillars of the response. | 10 June 2011 |
| An Alternative To Antibiotics Antibiotics are among the greatest achievements of medical science. But lately the former multi-purpose weapon fails in the battle against infectious diseases. Bacteria are increasingly developing resistance to antibiotics. | 10 June 2011 |
| IT / Internet / E-mail News | |
| Systems Made Simple Selected To Support Major National Initiative By The Department Of Veterans Affairs Systems Made Simple, Inc. (SMS), a leading provider of IT systems and services to support critical architecture, data and application challenges in the healthcare industry, announced it is part of a team that was awarded a contract under the Blanket Purchase Agreement (BPA) by the Department of Veterans Affairs (VA). | 10 June 2011 |
| Improved Modeling Of Biological Systems Using New Parallelization Technique Researchers at North Carolina State University have developed a new technique for using multi-core chips more efficiently, significantly enhancing a computer's ability to build computer models of biological systems. | 10 June 2011 |
| Litigation / Medical Malpractice News | |
| Mortality From All Causes Higher Among Hepatitis C-Infected Patients Although liver-related mortality among those infected with hepatitis C is well-documented, little is known about deaths in these patients that are not related to liver problems. A new study published in Clinical Infectious Diseases and now available online sought to determine mortality from all causes, including liver- and non-liver related deaths among hepatitis C patients in the general U. | 10 June 2011 |
| Ruling In Private Pension Case Could Have Implications For Retirees A recent U.S. Supreme Court decision could have a great deal of significance for employees and retirees with a private pension plan, a University of Illinois elder law expert says.According to law professor Richard L. | 10 June 2011 |
| Liver Disease / Hepatitis News | |
| Congress: Penny Watson Explores Liver Disease And Canine Pancreatitis, UK Built-in obsolescence is a problem usually associated with consumer products - but it is also a feature of a veterinary qualification. It is why practitioners need to keep on doing their postgraduate training (or Continuing Professional Development) - so that they can find out which facts they learned as gospel truth at vet school turns out to be completely wrong. | 10 June 2011 |
| Grant To Pursue Innovative Research To Develop Personalized Medicine The Research Institute of the McGill University Health Centre (RI-MUHC) was one of three winners in the Fonds de la recherche en sante du Quebec (FRSQ) competition 2011-2012. The RI-MUHC won in the category of Projects for innovative strategic development aimed at supporting projects essential to maintaining the competitiveness of a research centre. | 10 June 2011 |
| Lymphoma / Leukemia / Myeloma News | |
| Blinatumomab Achieved 75% Complete Remission In Acute Relapsing Lymphoblastic Leukemia Patients 75% of acute lymphoblastic leukemia patients who had relapsed after standard therapy achieved complete remission with blinatumomab, a medication designed to harness T cells that destroy cancer cells. | 10 June 2011 |
| Study Demonstrates Micromet's Blinatumomab Produces High Single-Agent Activity In Patients With Relapsed Acute Lymphoblastic Leukemia Data to be presented tomorrow at the 16th Annual Meeting of the European Hematology Association (EHA) in London, UK, show that Micromet's blinatumomab produced a high complete remission rate in adult patients with acute lymphoblastic leukemia (ALL) who had relapsed following treatment with standard therapy. | 10 June 2011 |
| Stem Cell Transplantation: A New Strategy For Treating Multiple Myeloma A new study has indicated the possible advantages of stem cell transplantation for patients with Multiple Myeloma, a cancer of plasma cells. Dr Antonio Palumbo: "This study shows a longer progression-free survival time with hematopoietic stem cell transplantation in comparison to conventional chemotherapy. | 10 June 2011 |
| Molecular Biologists Discover The Cause Of A Rare Type Of Leukemia During the annual meeting of the European Hematology Association (EHA) professor E. Tiacci from the Institute of Hematology in Perugia, Italy will present groundbreaking news on the cause of a specific, rare subtype of leukemia, so-called hairy cell leukemia. | 10 June 2011 |
| Stem Cell Time Bombs Cause Leukaemia Relapse, UK Leukaemia "stem cells" can lie dormant in the body for a decade or more after a child achieves remission before being reactivated and causing a relapse, a new study shows. Senior author Professor Mel Greaves from The Institute of Cancer Research (ICR) cautioned that the findings should not unduly concern parents whose children have previously suffered acute lymphoblastic leukaemia (ALL) as the leukaemia returning after very many years of remission is rare. | 10 June 2011 |
| Phase 3 Lymphoseek (Tilmanocept) Study Results Featured At Society Of Nuclear Medicine Annual Meeting Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that full results from the NEO3-05 study, demonstrating Lymphoseek® (99mTc-tilmanocept) met all primary and secondary endpoints in intraoperative lymphatic mapping (ILM) procedures. | 10 June 2011 |
| Remission Duration Of Lymphoma Doubled By New Therapy Clinical research has shown that recurrence of Mantle Cell Lymphoma, a variant of malignant lymphoma, can be reduced by almost 50% in patients who receive maintenance treatment with the antibody rituximab. | 10 June 2011 |
| Perceptive Informatics® Takes Lead In Practical Application Of Response Criteria For Lymphoma And Leukemia In Clinical Trials Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), announced that it is taking a lead role in the biopharmaceutical industry to advance the practical application of revised response criteria for Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) to clinical trials. | 10 June 2011 |
| Acute Myeloid Leukemia: Novel Developments In Treatment And Diagnosis Patients With Acute Myeloid Leukemia Receive Unnecessary High Doses Chemotherapy Patients with the most common form of leukemia (acute myeloid leukemia) receive ten times more chemotherapy than necessary. This was revealed by a team of Dutch hematologists. 'It is expected that this finding will lead to worldwide adjustments in the doses so that patients will experience less side-effects' says Dr Bob Löwenberg, Professor of Hematology at the Erasmus University Medical Center in Rotterdam, The Netherlands. | 10 June 2011 |
| Medical Devices / Diagnostics News | |
| NICE Consults On Programme Manual For Its Diagnostics Assessment Programme The National Institute for Health and Clinical Excellence (NICE) today opens its consultation on the programme manual outlining the proposed process and methods for its Diagnostics Assessment Programme. | 10 June 2011 |
| Promising New Imaging Tech For Diagnosis Of Cardiovascular Disease, Diabetes Researchers have developed a new type of imaging technology to diagnose cardiovascular disease and other disorders by measuring ultrasound signals from molecules exposed to a fast-pulsing laser. | 10 June 2011 |
| Ethicon Endo-Surgery Introduces ENDOPATH® XCEL™ With OPTIVIEW® Technology, Only 5mm Trocar Designed To Mitigate Smudging Of Endoscope Ethicon Endo-Surgery (EES) announced the launch of a new 5mm ENDOPATH® XCEL™ trocar enhanced with OPTIVIEW® Technology, the only trocar designed to mitigate smudging of the endoscope or laparoscope during surgical procedures. | 10 June 2011 |
| Medical Students / Training News | |
| Medical Training Under Threat From Proposed Immigration Changes, UK VSO and the Royal College of Physicians (RCP) are concerned that the government's proposed changes to immigration laws announced today, will have a significant impact on a training initiative that increases the quality of medical healthcare in the developing world and has significant benefits for the NHS. | 10 June 2011 |
| Medicare / Medicaid / SCHIP News | |
| HHS Delivers Guidance To State Medicaid Agencies On States' Freedom And Flexibility To Offer Financial Protections To Same-Sex Couples Today, HHS' Centers for Medicare & Medicaid Services (CMS) provided guidance to state Medicaid agencies clarifying that they are able to offer same-sex couples many of the same financial and asset protections available to opposite-sex couples when a partner is entering a nursing home or care facility. | 10 June 2011 |
| Pioneering Hospital Pay-For-Performance Program Falls Short Of Its Goals Massachusetts' innovative use of "pay-for-performance" bonuses to try to reduce racial and ethnic disparities in the case of Medicaid patients has turned up no evidence of the problem at any of the state's 66 acute-care hospitals, according to a new study that raises questions about the effectiveness of the state's novel approach. | 10 June 2011 |
| ANA Provides Testimony, Launches Website To Help Preserve Medicaid The American Nurses Association (ANA) is working on several fronts to counter attacks on Medicaid funding and keep nurses informed about the efforts on Capitol Hill that impact this program which provides essential health care coverage for an estimated 58 million Americans. | 10 June 2011 |
| Mental Health News | |
| Mental Health America To Honor Tulsa-Area Teen For Mental Health Work Mental Health America will honor Shawn Davis with its mpower award for her exceptional efforts to raise awareness of mental health issues among youth. The award will be presented at the closing night Awards Banquet of Mental Health America's 2010 Annual Conference in Washington, D. | 10 June 2011 |
| Multiple Sclerosis News | |
| Multiple Sclerosis And Related Disorders Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Multiple Sclerosis and Related Disorders with its first issue publication in January 2012. | 10 June 2011 |
| Neurology / Neuroscience News | |
| MDxHealth And Merck KGaA Extend Agreement For Use Of MGMT Assay In Brain Cancer Clinical Trials MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized medicine, announced today that it will extend its agreement with Merck KGaA, Darmstadt, Germany, for use of MDxHealth's MGMT assay in Merck KGaA's brain cancer clinical trials. | 10 June 2011 |
| Researchers Uncover The Source Of The Visual System's 'False Alarms' On rare occasion, the light-sensing photoreceptor cells in the eye misfire and signal to the brain as if they have captured photons, when in reality they haven't. For years this phenomenon remained a mystery. | 10 June 2011 |
| Fragile X Protein Acts As Toggle Switch In Brain Cells New research shows how the protein missing in fragile X syndrome - the most common inherited form of intellectual disability - acts as a molecular toggle switch in brain cells.The fragile X protein, called FMRP, hooks up with a group of molecules called microRNAs to switch the production of other proteins on and off in response to chemical signals, scientists at Emory University School of Medicine have discovered. | 10 June 2011 |
| Discovery Of How Nicotine Suppresses Appetite May Stop Weight Gain In Quitters A discovery of precisely how nicotine suppresses appetite, suggests it may be possible to develop drugs that help people stop gaining weight when they give up smoking, something that puts many smokers off quitting, according to a new study published online this week in the journal Science. | 10 June 2011 |
| Discovery of Site Of Nicotine Triggered Appetite Suppression May Lead To Quitting Without Weight Gain It is widely known that smoking inhibits appetite, but what is not known, is what triggers this process in the brain. Now researchers from Baylor College of Medicine, participating in a Yale University School of Medicine-led study, have identified the nicotine receptors that influence the anorexigenic signaling pathway, or appetite suppression pathway. | 10 June 2011 |
| Brain Imaging Study Of Preschoolers With ADHD Detects Brain Differences Linked To Symptoms In a study published today in the Clinical Neuropsychologist (e-publication ahead of print), researchers from the Kennedy Krieger Institute found differences in the brain development of preschool children with symptoms of Attention-deficit/Hyperactivity Disorder (ADHD). | 10 June 2011 |
| New Genetic Technique Converts Skin Cells Into Brain Cells A research breakthrough has proven that it is possible to reprogram mature cells from human skin directly into brain cells, without passing through the stem cell stage. The unexpectedly simple technique involves activating three genes in the skin cells; genes which are already known to be active in the formation of brain cells at the foetal stage. | 10 June 2011 |
| 3-D Movie Shows, For The First Time, What Happens In The Brain As It Loses Consciousness For the first time researchers have been able to watch what happens to the brain as it loses consciousness. Using sophisticated imaging equipment they have constructed a 3-D movie of the brain as it changes while an anaesthetic drug takes effect. | 10 June 2011 |
| Nursing / Midwifery News | |
| ANA Provides Testimony, Launches Website To Help Preserve Medicaid The American Nurses Association (ANA) is working on several fronts to counter attacks on Medicaid funding and keep nurses informed about the efforts on Capitol Hill that impact this program which provides essential health care coverage for an estimated 58 million Americans. | 10 June 2011 |
| Nutrition / Diet News | |
| E. Coli Outbreak, Vegetable Sprouts Most Likely The Cause, Say German Authorities The current E. coli outbreak probably originated in vegetable sprouts from an organic farm in northern Germany, spokespeople from the Robert Koch Institute, the Institute of Risk Management and the Ministry of Consumer Protection in Germany announced today. | 10 June 2011 |
| Athletes' Health Boosted By Non-Alcoholic Wheat Beer Many amateur athletes have long suspected what research scientists for the Department of Preventative and Rehabilitative Sports Medicine of the Technische Universitaet Muenchen at Klinikum rechts der Isar have now made official: Documented proof, gathered during the world's largest study of marathons, "Be-MaGIC" (beer, marathons, genetics, inflammation and the cardiovascular system), that the consumption of non-alcoholic weissbier, or wheat beer, has a positive effect on athletes' health. | 10 June 2011 |
| Fathers Have A Substantial Influence Over What Children Are Eating This Father's Day, dad's choice of where to eat could literally tip the scales on his children's health.A father's use of restaurants and his perceptions of family meals carry more weight, so to speak, than mothers', according to a Texas AgriLife Research study, published recently in The Journal of Nutrition Education and Behavior. | 10 June 2011 |
| Study Confirms Safety, Cancer-Targeting Ability Of Nutrient In Broccoli, Other Vegetables Sulforaphane, one of the primary phytochemicals in broccoli and other cruciferous vegetables that helps them prevent cancer, has been shown for the first time to selectively target and kill cancer cells while leaving normal prostate cells healthy and unaffected. | 10 June 2011 |
| Cancer Experts Offer Four Tips For Healthy Grilling It's that time of year again. Hot weather sets picnic fever - and the nation's barbeque grills - ablaze; in fact, according to the Hearth, Patio and Barbeque Association, 4 out of 5 American households will fire up backyard grills this summer. | 10 June 2011 |
| Obesity / Weight Loss / Fitness News | |
| Fathers Have A Substantial Influence Over What Children Are Eating This Father's Day, dad's choice of where to eat could literally tip the scales on his children's health.A father's use of restaurants and his perceptions of family meals carry more weight, so to speak, than mothers', according to a Texas AgriLife Research study, published recently in The Journal of Nutrition Education and Behavior. | 10 June 2011 |
| Discovery Of How Nicotine Suppresses Appetite May Stop Weight Gain In Quitters A discovery of precisely how nicotine suppresses appetite, suggests it may be possible to develop drugs that help people stop gaining weight when they give up smoking, something that puts many smokers off quitting, according to a new study published online this week in the journal Science. | 10 June 2011 |
| Discovery of Site Of Nicotine Triggered Appetite Suppression May Lead To Quitting Without Weight Gain It is widely known that smoking inhibits appetite, but what is not known, is what triggers this process in the brain. Now researchers from Baylor College of Medicine, participating in a Yale University School of Medicine-led study, have identified the nicotine receptors that influence the anorexigenic signaling pathway, or appetite suppression pathway. | 10 June 2011 |
| Pain / Anesthetics News | |
| Physician Participation In Lethal Injection Executions Should Not Be Banned, Argue Two Ethicists Should physicians be banned from assisting in a lethal injection execution, or lose professional certification for doing so? A recent ruling by the American Board of Anesthesiology will revoke certification of anesthesiologists who participate in capital punishment, and other medical boards may act similarly. | 10 June 2011 |
| Parkinson's Disease News | |
| Abbott Reports Interim Results From Phase III Open-Label Study Of Investigational Treatment For Advanced Parkinson's Disease Interim efficacy and safety results from a long-term, 54-week, Phase III open-label study of Abbott's investigational treatment for advanced Parkinson's disease showed that patients treated with levodopa-carbidopa intestinal gel (LCIG) for 12 weeks reported a decrease in "off" time and an increase in "on" time without troublesome dyskinesias. | 10 June 2011 |
| New Animal Study Shows Promise For Development Of Parkinson's Disease Drug Few treatments for Parkinson's disease (PD) restore function for extended periods. In a new study published in the inaugural issue of the Journal of Parkinson's Disease, an international group of researchers report that platelet-derived growth factor-BB (PDGF-BB) restored function in rodents and shows promise as a clinical candidate drug for treatment of PD. | 10 June 2011 |
| New Method For Measuring Parkinson's Disease Prevalence Reveals Sharp Increase In Israel In a new study published in the inaugural issue of the Journal of Parkinson's Disease, Israeli researchers report that by tracking pharmacy purchases of anti-Parkinson drugs they could estimate the number of Parkinson's disease (PD) cases in a large population. | 10 June 2011 |
| Landmark Study Analyzes Scientific Productivity And Impact Of The Top 100 Parkinson's Disease Investigators IOS Press is pleased to announce the publication of a landmark study in which both traditional and innovative scientometric approaches have been employed to identify the top 100 Parkinson's disease (PD) investigators since 1985 and measure their scientific productivity as well as the impact of their contributions to the field. | 10 June 2011 |
| Pediatrics / Children's Health News | |
| EPA Regulators Should Not Hide Behind Children To Push For Costly New Regulations On June 8, 2011, the Senate Subcommittee on Clean Air and Nuclear Safety and the Subcommittee on Children's Health and Environmental Responsibility of the Senate Committee on Environment and Public Works held a joint hearing on, "Air Quality and Children's Health. | 10 June 2011 |
| Link Between Large-Scale Early Education And Higher Living Standards And Crime Prevention 25 Years Later High-quality early education has a strong, positive impact well into adulthood, according to research led by Arthur Reynolds, co-director of the Human Capital Research Collaborative and professor of child development, and Judy Temple, a professor in the Humphrey School of Public Affairs at the University of Minnesota. | 10 June 2011 |
| Fathers Have A Substantial Influence Over What Children Are Eating This Father's Day, dad's choice of where to eat could literally tip the scales on his children's health.A father's use of restaurants and his perceptions of family meals carry more weight, so to speak, than mothers', according to a Texas AgriLife Research study, published recently in The Journal of Nutrition Education and Behavior. | 10 June 2011 |
| Mutations In Essential Genes Often Cause Rare Diseases Mutations in genes essential to survival are behind so-called orphan diseases, explaining in part why these diseases are rare and often deadly, according to a study appearing in The American Journal of Human Genetics. | 10 June 2011 |
| Pharma Industry / Biotech Industry News | |
| Improved Modeling Of Biological Systems Using New Parallelization Technique Researchers at North Carolina State University have developed a new technique for using multi-core chips more efficiently, significantly enhancing a computer's ability to build computer models of biological systems. | 10 June 2011 |
| Chemists Devise Better Way To Prepare Workhorse Molecules In chemistry, so-called aromatic molecules compose a large and versatile family of chemical compounds that are the stuff of pharmaceuticals, electronic materials and consumer products ranging from sunscreen to plastic soda bottles. | 10 June 2011 |
| FDA Takes 'First Step' Toward Greater Regulatory Certainty Around Nanotechnology The U.S. Food and Drug Administration today released draft guidance to provide regulated industries with greater certainty about the use of nanotechnology, which generally involves materials made up of particles that are at least one billionth of a meter in size. | 10 June 2011 |
| Pharmacy / Pharmacist News | |
| Flexibility In Initiating RMMRs Essential, Australia Changes to the Residential Medication Management Review (RMMR) Program which stipulate that in future all reviews must be collaborative could have the unintended consequence of reducing flexibility in the system, the Pharmaceutical Society of Australia says. | 10 June 2011 |
| Primary Care / General Practice News | |
| GPs Say They Don't Have The Skills To Run NHS Budgets - New Survey From Biggest GP Conference This Year, UK A new survey has delivered a damning indictment of the Prime Minister's revised NHS plans. GPs and primary healthcare professionals attending the Health Commissioning conference at Olympia on Wednesday, 15th and Thursday, 16th June have raised serious and urgent concerns with the government's approach to healthcare reforms, and with the Prime Minister's personal commitments. | 10 June 2011 |
| Physician Participation In Lethal Injection Executions Should Not Be Banned, Argue Two Ethicists Should physicians be banned from assisting in a lethal injection execution, or lose professional certification for doing so? A recent ruling by the American Board of Anesthesiology will revoke certification of anesthesiologists who participate in capital punishment, and other medical boards may act similarly. | 10 June 2011 |
| Medical Training Under Threat From Proposed Immigration Changes, UK VSO and the Royal College of Physicians (RCP) are concerned that the government's proposed changes to immigration laws announced today, will have a significant impact on a training initiative that increases the quality of medical healthcare in the developing world and has significant benefits for the NHS. | 10 June 2011 |
| Prostate / Prostate Cancer News | |
| AUA Statement Regarding Infections Secondary To Transrectal Prostate Needle Biopsies Research reports suggest that the rate of infectious complications, including sepsis, after transrectal prostate needle biopsy may be increasing. Recently published news articles highlighted these findings, and it is important for urologists to be aware of this issue. | 10 June 2011 |
| Finasteride And Dutasteride Raise Risk Of High-Grade Prostate Cancer, FDA Informs Although finasteride and dutasteride lower overall risk of developing prostate cancer, they raise the chances of developing high-grade prostate cancer, a more serious form of the disease, the FDA (Food and Drug Administration) has announced. | 10 June 2011 |
| Study Confirms Safety, Cancer-Targeting Ability Of Nutrient In Broccoli, Other Vegetables Sulforaphane, one of the primary phytochemicals in broccoli and other cruciferous vegetables that helps them prevent cancer, has been shown for the first time to selectively target and kill cancer cells while leaving normal prostate cells healthy and unaffected. | 10 June 2011 |
| Radiation Right After Prostate Removal Is Cost-Effective, But Less Likely To Be Recommended By Urologists Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels, according to a new study by researchers at Thomas Jefferson University and Hospital. | 10 June 2011 |
| Psychology / Psychiatry News | |
| Ingratiation Used By Politically Savvy Individuals Neutralizes Psychological Distress Savvy career minded individuals have known for some time that ingratiating oneself to the boss and others - perhaps more commonly known as 'sucking up'- can help move them up the corporate ladder more quickly. | 10 June 2011 |
| Police Officer May Have Been Wrongfully Convicted For Missing The 'Obvious' Suggests Study In a new study, researchers tested the claims of a Boston police officer who said he ran past a brutal police beating without seeing it. After re-creating some of the conditions of the original incident and testing the perceptions of college students who ran past a staged fight, the researchers found the officer's story plausible. | 10 June 2011 |
| Brain Imaging Study Of Preschoolers With ADHD Detects Brain Differences Linked To Symptoms In a study published today in the Clinical Neuropsychologist (e-publication ahead of print), researchers from the Kennedy Krieger Institute found differences in the brain development of preschool children with symptoms of Attention-deficit/Hyperactivity Disorder (ADHD). | 10 June 2011 |
| Public Health News | |
| NAO Report Highlights The Central Role Ambulances Have To Play In NHS, UK By working together across the NHS system, ambulance services can reach the potential set out in a National Audit Office report on ambulance services says Ambulance Service Network director Jo WebberAmbulance Service Network director Jo Webber said:"The ambulance service has a pivotal role to play in the performance of the entire urgent and emergency care system. | 10 June 2011 |
| E. Coli Outbreak, Vegetable Sprouts Most Likely The Cause, Say German Authorities The current E. coli outbreak probably originated in vegetable sprouts from an organic farm in northern Germany, spokespeople from the Robert Koch Institute, the Institute of Risk Management and the Ministry of Consumer Protection in Germany announced today. | 10 June 2011 |
| SUVs Still Not Teen-Safe, Despite Institute Report Controllable Speeding, Not Rollover, Is Major Death Threat A report recommending that parents consider purchasing an SUV for their teen drivers, based on findings that electronic control systems now minimize rollovers, is incomplete and potentially misleading because the Insurance Institute for Highway Safety completely overlooked another important existing vehicle safety system which is far more important because it would slash deaths and injuries in high-speed crashes - which are much more common than rollovers for teen drivers. | 10 June 2011 |
| Introduction Of Bar Codes Will Save NHS Millions, UK A new system to tackle variation in how much NHS hospitals pay for products was announced by Health Minister Simon Burns today.Some hospitals are currently paying nearly three times as much as others for the same products like surgical gloves and stents. | 10 June 2011 |
| NCD Alliance Launches '100 Days Of Action' With the UN High-Level Summit on Non-Communicable Diseases1 (NCDs) opening in 100 days, the NCD Alliance today called on all those concerned to make themselves heard by heads of state and health decision makers. | 10 June 2011 |
| Pioneering Hospital Pay-For-Performance Program Falls Short Of Its Goals Massachusetts' innovative use of "pay-for-performance" bonuses to try to reduce racial and ethnic disparities in the case of Medicaid patients has turned up no evidence of the problem at any of the state's 66 acute-care hospitals, according to a new study that raises questions about the effectiveness of the state's novel approach. | 10 June 2011 |
| Link Between Large-Scale Early Education And Higher Living Standards And Crime Prevention 25 Years Later High-quality early education has a strong, positive impact well into adulthood, according to research led by Arthur Reynolds, co-director of the Human Capital Research Collaborative and professor of child development, and Judy Temple, a professor in the Humphrey School of Public Affairs at the University of Minnesota. | 10 June 2011 |
| Study Explores How Dogs Think And Learn About Human Behavior Can dogs read our minds? How do they learn to beg for food or behave badly primarily when we're not looking? According to Monique Udell and her team, from the University of Florida in the US, the way that dogs come to respond to the level of people's attentiveness tells us something about the ways dogs think and learn about human behavior. | 10 June 2011 |
| The NHS To Use New Hospital Mortality Rate Index A team from the University of Sheffield's School of Health and Related Research (ScHARR) has developed a new index to measure hospital mortality rates that has been accepted for use by the Department of Health. | 10 June 2011 |
| HHS Toolkit Of Public Health Emergency Text Messages Now Available A new toolkit of prepared cell phone text messages advising people how to protect their health after a disaster is available now through the U.S. Department of Health and Human Services. These messages support state and local emergency managers in disaster response and are available online here. | 10 June 2011 |
| Chemists Devise Better Way To Prepare Workhorse Molecules In chemistry, so-called aromatic molecules compose a large and versatile family of chemical compounds that are the stuff of pharmaceuticals, electronic materials and consumer products ranging from sunscreen to plastic soda bottles. | 10 June 2011 |
| Radiology / Nuclear Medicine News | |
| Congress: Interpreting Chest X-Rays With Mantis, UK Every picture tells a story - but if it's a thoracic radiograph that you are looking at, you may find that the narrative is muddled and difficult to follow.So that is why Panagiotis 'Pete' Mantis, senior lecturer in diagnostic imaging at the Royal Veterinary College near Potters Bar, is giving a presentation on interpreting chest X-rays of small animal patients for colleagues in first opinion practice at this year's BVA Congress as part of the BSAVA sessions. | 10 June 2011 |
| GE Healthcare's AngioViz Vascular Vision Software Receives FDA Clearance GE Healthcare (NYSE:GE) today announced the FDA clearance of AngioViz, an application that gives doctors a new visualization of vascular flow on a single image to help them make important decisions during complex interventional radiology procedures. | 10 June 2011 |
| Phase 3 Lymphoseek (Tilmanocept) Study Results Featured At Society Of Nuclear Medicine Annual Meeting Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that full results from the NEO3-05 study, demonstrating Lymphoseek® (99mTc-tilmanocept) met all primary and secondary endpoints in intraoperative lymphatic mapping (ILM) procedures. | 10 June 2011 |
| Radiation Right After Prostate Removal Is Cost-Effective, But Less Likely To Be Recommended By Urologists Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels, according to a new study by researchers at Thomas Jefferson University and Hospital. | 10 June 2011 |
| Regulatory Affairs / Drug Approvals News | |
| FDA Accepts Filing Of New Drug Application For Nycomed's Ciclesonide HFA Nasal Aerosol Nycomed's licensing partner Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation. | 10 June 2011 |
| Finasteride And Dutasteride Raise Risk Of High-Grade Prostate Cancer, FDA Informs Although finasteride and dutasteride lower overall risk of developing prostate cancer, they raise the chances of developing high-grade prostate cancer, a more serious form of the disease, the FDA (Food and Drug Administration) has announced. | 10 June 2011 |
| Diabetes Drugs Actos And Competact Suspended In France And Germany, Potential Bladder Cancer Risk After a study showed a slight increased risk of developing bladder cancer among patients taking Actos (pioglitazone) and Competact (metformin with pioglitazone), French regulators announced that they have suspended the use of Actos and Competact, both diabetes medications. | 10 June 2011 |
| GE Healthcare's AngioViz Vascular Vision Software Receives FDA Clearance GE Healthcare (NYSE:GE) today announced the FDA clearance of AngioViz, an application that gives doctors a new visualization of vascular flow on a single image to help them make important decisions during complex interventional radiology procedures. | 10 June 2011 |
| FDA Takes 'First Step' Toward Greater Regulatory Certainty Around Nanotechnology The U.S. Food and Drug Administration today released draft guidance to provide regulated industries with greater certainty about the use of nanotechnology, which generally involves materials made up of particles that are at least one billionth of a meter in size. | 10 June 2011 |
| Tengion Announces FDA Orphan-Drug Designation For Neo-Urinary Conduit Tengion, Inc. (Nasdaq: TNGN) announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to the Company's Neo-Urinary Conduit™, for treatment of bladder dysfunction requiring incontinent urinary diversion. | 10 June 2011 |
| Respiratory / Asthma News | |
| Forest Laboratories, Inc. Announces Availability Of Daliresp™ In Pharmacies Forest Laboratories, Inc. (NYSE: FRX) announced today that Daliresp™ (roflumilast) will be available in pharmacies throughout the United States by mid-June. The U.S. Food and Drug Administration (FDA) recently approved Daliresp as a treatment to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. | 10 June 2011 |
| EPA Regulators Should Not Hide Behind Children To Push For Costly New Regulations On June 8, 2011, the Senate Subcommittee on Clean Air and Nuclear Safety and the Subcommittee on Children's Health and Environmental Responsibility of the Senate Committee on Environment and Public Works held a joint hearing on, "Air Quality and Children's Health. | 10 June 2011 |
| Respira Therapeutics Introduces Breakthrough Solutions For Respiratory Diseases Respira Therapeutics, a product development company focused on inhaled therapeutics to improve patients' lives, introduces the company's Dry Powder Inhaler (DPI) as a breakthrough solution for the pharmaceutical industry. | 10 June 2011 |
| Restless Legs Syndrome News | |
| New Post Hoc Analyses Examined The Effects Of Neupro(R) (Rotigotine) On Daytime Functioning, Daytime Symptoms, Pain And Mood In Restless Legs Syndrome Results from new post hoc analyses assessing the effects of Neupro® (rotigotine) in Restless Legs Syndrome (RLS) and utilizing novel surrogate markers suggested improved daytime functioning and daytime symptoms, reduced RLS-related pain and improved mood and depressive symptoms in patients with moderate to severe RLS 1-3. | 10 June 2011 |
| Seniors / Aging News | |
| Heat Hits Elderly Harder; Extra Precautions Are Needed The hot weather prompts many people to flock indoors and crank up the air conditioner. It is especially necessary during these times to not overlook one population - the elderly.Richard Allman, M. | 10 June 2011 |
| Report Reveals Care Industry On Brink Of Collapse, UK A new UNISON report, delving into the running and funding of the care industry, reveals that the collapse of Southern Cross may not be a one-off, as a number of other social care companies are also on the brink. | 10 June 2011 |
| Ruling In Private Pension Case Could Have Implications For Retirees A recent U.S. Supreme Court decision could have a great deal of significance for employees and retirees with a private pension plan, a University of Illinois elder law expert says.According to law professor Richard L. | 10 June 2011 |
| Sleep / Sleep Disorders / Insomnia News | |
| Inspire Medical Systems Reaches Milestones With Its Sleep Apnea Therapy Inspire Medical Systems, the leading developer of neurostimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today The STAR trial (Stimulation Therapy for Apnea Reduction), evaluating both the safety and effectiveness of Inspire™ Upper Airway Stimulation (UAS) therapy, is currently underway at 9 leading medical centers across the United States and at 4 sites in Europe. | 10 June 2011 |
| Smoking / Quit Smoking News | |
| Discovery Of How Nicotine Suppresses Appetite May Stop Weight Gain In Quitters A discovery of precisely how nicotine suppresses appetite, suggests it may be possible to develop drugs that help people stop gaining weight when they give up smoking, something that puts many smokers off quitting, according to a new study published online this week in the journal Science. | 10 June 2011 |
| Discovery of Site Of Nicotine Triggered Appetite Suppression May Lead To Quitting Without Weight Gain It is widely known that smoking inhibits appetite, but what is not known, is what triggers this process in the brain. Now researchers from Baylor College of Medicine, participating in a Yale University School of Medicine-led study, have identified the nicotine receptors that influence the anorexigenic signaling pathway, or appetite suppression pathway. | 10 June 2011 |
| Smoking Quitlines Work Regardless Of How Smokers Are Recruited Proactive telephone counseling helps smokers quit regardless of how they are recruited to a telephone quitline, according to a study published online June 10th in the Journal of the National Cancer Institute. | 10 June 2011 |
| Sports Medicine / Fitness News | |
| Arthritis Epidemic Looming In UK, High Heels Partly To Blame Inadquate footwear such as high heels is partly to blame for the arthritis problem that is in danger of reaching epidemic proportions in the UK where already one in four adults has a muskuloskeletal condition, with 60% of arthritis cases being in the feet. | 10 June 2011 |
| Athletes' Health Boosted By Non-Alcoholic Wheat Beer Many amateur athletes have long suspected what research scientists for the Department of Preventative and Rehabilitative Sports Medicine of the Technische Universitaet Muenchen at Klinikum rechts der Isar have now made official: Documented proof, gathered during the world's largest study of marathons, "Be-MaGIC" (beer, marathons, genetics, inflammation and the cardiovascular system), that the consumption of non-alcoholic weissbier, or wheat beer, has a positive effect on athletes' health. | 10 June 2011 |
| Stem Cell Research News | |
| Stem Cell Transplantation: A New Strategy For Treating Multiple Myeloma A new study has indicated the possible advantages of stem cell transplantation for patients with Multiple Myeloma, a cancer of plasma cells. Dr Antonio Palumbo: "This study shows a longer progression-free survival time with hematopoietic stem cell transplantation in comparison to conventional chemotherapy. | 10 June 2011 |
| Stem Cell Time Bombs Cause Leukaemia Relapse, UK Leukaemia "stem cells" can lie dormant in the body for a decade or more after a child achieves remission before being reactivated and causing a relapse, a new study shows. Senior author Professor Mel Greaves from The Institute of Cancer Research (ICR) cautioned that the findings should not unduly concern parents whose children have previously suffered acute lymphoblastic leukaemia (ALL) as the leukaemia returning after very many years of remission is rare. | 10 June 2011 |
| Cord Blood Banks Contain More Than 500.000 Umbilical Cord Blood Units Advantages Of Cord Blood Stem Cell Transplantation Established Since the first human cord blood transplant, performed in 1988, the safety and efficacy of umbilical cord blood transplantation in both children and adults with a variety of malignant and non-malignant diseases have been clearly established. | 10 June 2011 |
| UCLA Researchers Given Early Access To Leading-Edge Technologies An agreement between UCLA and Roche will provide stem cell and cancer researchers with leading-edge technologies that will drive research capabilities and further the understanding of complex disease. | 10 June 2011 |
| Signaling Pathways Point To Vulnerability In Breast Cancer Stem Cells Whitehead Institute researchers have identified signals from breast epithelial cells that can induce those cells to transition to and maintain a mesenchymal and stem cell-like cell state that imbues both normal and cancer cells with a greater ability to migrate and self-renew. | 10 June 2011 |
| Stanford Expert Warns That Curtailing Embryonic Stem Cell Research Would Also Hurt IPS Cell Research Any legislation that slows human embryonic stem cell research is likely to also seriously harm the study of induced pluripotent stem cells, according to a new study by researchers at the Stanford University School of Medicine, the Mayo Clinic and the University of Michigan. | 10 June 2011 |
| New Genetic Technique Converts Skin Cells Into Brain Cells A research breakthrough has proven that it is possible to reprogram mature cells from human skin directly into brain cells, without passing through the stem cell stage. The unexpectedly simple technique involves activating three genes in the skin cells; genes which are already known to be active in the formation of brain cells at the foetal stage. | 10 June 2011 |
| Transplants / Organ Donations News | |
| Woman Receives Full Face Transplant After Being Mauled By A Chimpanzee Charla Nash, 57, whose face was mauled by a furious 200-pound pet chimpanzee in February 2009, has undergone a full face transplant at Brigham and Women's Hospital, Dr. Bohdan Pomahac, medical team leader announced. | 10 June 2011 |
| Cord Blood Banks Contain More Than 500.000 Umbilical Cord Blood Units Advantages Of Cord Blood Stem Cell Transplantation Established Since the first human cord blood transplant, performed in 1988, the safety and efficacy of umbilical cord blood transplantation in both children and adults with a variety of malignant and non-malignant diseases have been clearly established. | 10 June 2011 |
| Tropical Diseases News | |
| Research Aims To Explore Untapped Opportunities To Combat Malaria Parasite In Liver A scientist from The Scripps Research Institute has won a four-year, $1.9 million grant from the National Institutes of Health to better understand the parasite that causes malaria, laying the groundwork to develop better drugs to combat the widespread and deadly disease. | 10 June 2011 |
| New Evidence Of Genetic 'Arms Race' Against Malaria For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back. | 10 June 2011 |
| Cellectis And VitamFero Collaborate To Develop Vaccines Against Parasitic Infection Cellectis (Alternext: ALCLS), the genome engineering specialist, and VitamFero, a biotech company of the Genopole® portfolio developing new vaccines against parasite infections, today announced the signing of a research, development and licensing partnership agreement. | 10 June 2011 |
| State's Earliest West Nile Virus Detection Reported In Greene County Pennsylvania has reported its earliest detection of a West Nile virus-carrying mosquito since testing began in 2000, the Department of Environmental Protection said today. The first detection of 2011 was a mosquito collection in Morgan Township, Greene County, on May 17. | 10 June 2011 |
| Urology / Nephrology News | |
| AUA Statement Regarding Infections Secondary To Transrectal Prostate Needle Biopsies Research reports suggest that the rate of infectious complications, including sepsis, after transrectal prostate needle biopsy may be increasing. Recently published news articles highlighted these findings, and it is important for urologists to be aware of this issue. | 10 June 2011 |
| Finasteride And Dutasteride Raise Risk Of High-Grade Prostate Cancer, FDA Informs Although finasteride and dutasteride lower overall risk of developing prostate cancer, they raise the chances of developing high-grade prostate cancer, a more serious form of the disease, the FDA (Food and Drug Administration) has announced. | 10 June 2011 |
| Tengion Announces FDA Orphan-Drug Designation For Neo-Urinary Conduit Tengion, Inc. (Nasdaq: TNGN) announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to the Company's Neo-Urinary Conduit™, for treatment of bladder dysfunction requiring incontinent urinary diversion. | 10 June 2011 |
| Radiation Right After Prostate Removal Is Cost-Effective, But Less Likely To Be Recommended By Urologists Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels, according to a new study by researchers at Thomas Jefferson University and Hospital. | 10 June 2011 |
| Vascular News | |
| GE Healthcare's AngioViz Vascular Vision Software Receives FDA Clearance GE Healthcare (NYSE:GE) today announced the FDA clearance of AngioViz, an application that gives doctors a new visualization of vascular flow on a single image to help them make important decisions during complex interventional radiology procedures. | 10 June 2011 |
| Veterans / Ex-Servicemen News | |
| Systems Made Simple Selected To Support Major National Initiative By The Department Of Veterans Affairs Systems Made Simple, Inc. (SMS), a leading provider of IT systems and services to support critical architecture, data and application challenges in the healthcare industry, announced it is part of a team that was awarded a contract under the Blanket Purchase Agreement (BPA) by the Department of Veterans Affairs (VA). | 10 June 2011 |
| Veterinary News | |
| Congress: Penny Watson Explores Liver Disease And Canine Pancreatitis, UK Built-in obsolescence is a problem usually associated with consumer products - but it is also a feature of a veterinary qualification. It is why practitioners need to keep on doing their postgraduate training (or Continuing Professional Development) - so that they can find out which facts they learned as gospel truth at vet school turns out to be completely wrong. | 10 June 2011 |
| Congress: Interpreting Chest X-Rays With Mantis, UK Every picture tells a story - but if it's a thoracic radiograph that you are looking at, you may find that the narrative is muddled and difficult to follow.So that is why Panagiotis 'Pete' Mantis, senior lecturer in diagnostic imaging at the Royal Veterinary College near Potters Bar, is giving a presentation on interpreting chest X-rays of small animal patients for colleagues in first opinion practice at this year's BVA Congress as part of the BSAVA sessions. | 10 June 2011 |
| Congress: Alex German To Take The Frustration Out Of Canine IBD, UK When a dog turns up in their consulting room with chronic diarrhoea, vomiting and weight loss, then it is quite likely that the vet will call it a case of inflammatory bowel disease. But that is probably the only thing that they can say with any confidence after identifying one of the most enigmatic and frustrating conditions seen in small animal practice. | 10 June 2011 |
| Study Explores How Dogs Think And Learn About Human Behavior Can dogs read our minds? How do they learn to beg for food or behave badly primarily when we're not looking? According to Monique Udell and her team, from the University of Florida in the US, the way that dogs come to respond to the level of people's attentiveness tells us something about the ways dogs think and learn about human behavior. | 10 June 2011 |
| Water - Air Quality / Agriculture News | |
| EPA Regulators Should Not Hide Behind Children To Push For Costly New Regulations On June 8, 2011, the Senate Subcommittee on Clean Air and Nuclear Safety and the Subcommittee on Children's Health and Environmental Responsibility of the Senate Committee on Environment and Public Works held a joint hearing on, "Air Quality and Children's Health. | 10 June 2011 |
| 'Super Varieties' Of Wheat Expected To Boost Yields And Block Deadly Threat To Food Security Five years after the launch of a global effort to protect the world's most important food crop from variants of Ug99, a new and deadly form of wheat rust, scientists say they are close to producing super varieties of wheat that will resist the potent pathogen, while boosting yields by as much as 15 percent. | 10 June 2011 |
| Help Save Our Forests: Don't Move Firewood, Canada During Canadian Environment Week, the Canadian Food Inspection Agency (CFIA) wants to remind Canadians about one simple thing they can do to help preserve our forests from invasive species such as harmful insects: don't move firewood. | 10 June 2011 |
| You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
Tidak ada komentar:
Posting Komentar